What drugs target p40 subunit of IL-12 and IL-23?

3+ drugs target p40 subunit of IL-12 and IL-23, including .

What drug classes act on p40 subunit of IL-12 and IL-23?

Drug classes acting on p40 subunit of IL-12 and IL-23 include IL-12/23 inhibitor.

3 drugs 3 in Phase 3

All drugs that target p40 subunit of IL-12 and IL-23 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Ustekinumab - Half-Standard Dosage · Janssen Research & Development, LLC · IL-12/23 inhibitor · Immunology
Ustekinumab is a monoclonal antibody that blocks the action of interleukin-12 and interleukin-23, which are proteins involved in inflammation.
Ustekinumab (90 mg) · Janssen Scientific Affairs, LLC · IL-12/23 inhibitor · Immunology
Ustekinumab is a monoclonal antibody that targets and binds to the p40 subunit of interleukin-12 (IL-12) and interleukin-23 (IL-23), thereby inhibiting their activity and reducing inflammation.
Ustekinumab - Standard Dosage · Humanitas Clinical and Research Center · IL-12/23 inhibitor · Immunology
Ustekinumab is a monoclonal antibody that targets and binds to the p40 subunit of interleukin-12 (IL-12) and interleukin-23 (IL-23), thereby inhibiting their activity and reducing inflammation.